Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02908672 |
|---|---|
| Brief Title: | A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma |
| First Submitted : | September 19, 2016 |
| First Submitted that Met QC Criteria : | September 19, 2016 |
| First Posted : | September 21, 2016 (Estimate) |
| Results First Submitted : | September 15, 2020 |
| Results First Submitted that Met QC Criteria : | October 26, 2020 |
| Results First Posted : | November 19, 2020 |
| Last Update Submitted that Met QC Criteria : | March 21, 2024 |
| Last Update Posted : | March 22, 2024 |